Functional Fv fragment of an antibody specific for CD28: Fv-mediated co-stimulation of T cells

被引:7
作者
Takemura, S
Asano, R
Tsumoto, K
Arai, T
Sakurai, N
Kodama, H
Yoshida, H
Katayose, Y
Suzuki, M
Matsuno, S
Kudo, T
Kumagai, I
机构
[1] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan
[2] Tohoku Univ, Sch Med, Dept Surg 1, Aoba Ku, Sendai, Miyagi 9808579, Japan
[3] Tohoku Univ, Inst Dev Aging & Canc, Cell Resources Ctr Biomed Res, Aoba Ku, Sendai, Miyagi 9808575, Japan
关键词
CD28-B7; co-stimulation; Fv; bacterial expression; immunotherapy;
D O I
10.1016/S0014-5793(00)01741-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The most predominant co-stimulation pathway, which is critical for T cell activation and proliferation, is the CD28-B7 pathway, The anti-CD28 monoclonal antibody (mAb) also provides a co-stimulatory signal to T cells. In order to construct a functional Fv fragment (complex of VH and VL domains) of anti-CD28 antibody using a bacterial expression system, cDNA encoding the variable regions of immunoglobulin from 15E8 hybridoma cells was cloned and expressed in Escherichia coli, The Fv fragment was obtained as a soluble protein from the periplasmic fraction and showed a binding pattern similar to parental IgG, The Fv fragment induced proliferation of peripheral blood mononuclear cells in the presence of anti-CD3 or anti-CD2 mAb and enhanced anti-tumor activity of antiMUC1 X anti-CD3 bispecific antibody when tested with lymphokine-activated killer cells with T cell phenotype. Thus, the anti-CD28 Fv fragment will be promising not only for the study of costimulation, but also for cancer immunotherapy. (C) 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:266 / 271
页数:6
相关论文
共 27 条
  • [1] CD28 INTERACTION WITH B7-COSTIMULATES PRIMARY ALLOGENEIC PROLIFERATIVE RESPONSES AND CYTOTOXICITY MEDIATED BY SMALL, RESTING LYMPHOCYTES-T
    AZUMA, M
    CAYABYAB, M
    BUCK, D
    PHILLIPS, JH
    LANIER, LL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) : 353 - 360
  • [2] SINGLE-CHAIN ANTIGEN-BINDING PROTEINS
    BIRD, RE
    HARDMAN, KD
    JACOBSON, JW
    JOHNSON, S
    KAUFMAN, BM
    LEE, SM
    LEE, T
    POPE, SH
    RIORDAN, GS
    WHITLOW, M
    [J]. SCIENCE, 1988, 242 (4877) : 423 - 426
  • [3] CERDAN C, 1995, J IMMUNOL, V154, P1007
  • [4] CERDAN C, 1992, J IMMUNOL, V149, P2255
  • [5] REGULATION OF T-CELL LYMPHOKINE GENE-TRANSCRIPTION BY THE ACCESSORY MOLECULE CD28
    FRASER, JD
    WEISS, A
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (10) : 4357 - 4363
  • [6] REGULATION OF INTERLEUKIN-2 GENE ENHANCER ACTIVITY BY THE T-CELL ACCESSORY MOLECULE CD28
    FRASER, JD
    IRVING, BA
    CRABTREE, GR
    WEISS, A
    [J]. SCIENCE, 1991, 251 (4991) : 313 - 316
  • [7] CLONING OF B7-2 - A CTLA-4 COUNTER-RECEPTOR THAT COSTIMULATES HUMAN T-CELL PROLIFERATION
    FREEMAN, GJ
    GRIBBEN, JG
    BOUSSIOTIS, VA
    NG, JW
    RESTIVO, VA
    LOMBARD, LA
    GRAY, GS
    NADLER, LM
    [J]. SCIENCE, 1993, 262 (5135) : 909 - 911
  • [8] B7-1 AND B7-2 DO NOT DELIVER IDENTICAL COSTIMULATORY SIGNALS, SINCE B7-2 BUT NOT B7-1 PREFERENTIALLY COSTIMULATES THE INITIAL PRODUCTION OF IL-4
    FREEMAN, GJ
    BOUSSIOTIS, VA
    ANUMANTHAN, A
    BERNSTEIN, GM
    KE, XY
    RENNERT, PD
    GRAY, GS
    GRIBBEN, JG
    NADLER, LM
    [J]. IMMUNITY, 1995, 2 (05) : 523 - 532
  • [9] B-CELL SURFACE ANTIGEN-B7 PROVIDES A COSTIMULATORY SIGNAL THAT INDUCES T-CELLS TO PROLIFERATE AND SECRETE INTERLEUKIN-2
    GIMMI, CD
    FREEMAN, GJ
    GRIBBEN, JG
    SUGITA, K
    FREEDMAN, AS
    MORIMOTO, C
    NADLER, LM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) : 6575 - 6579
  • [10] Helfrich W, 1998, INT J CANCER, V76, P232, DOI 10.1002/(SICI)1097-0215(19980413)76:2<232::AID-IJC11>3.3.CO